4Suppliers
8Customers
1Debt Items
20Related Chains

Medpace Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
IQV IQVIA Holdings Inc. 72% d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, the management of sales force effectiveness and the creation of a process whereby…
IQV IQVIA Holdings Inc. 72% Reciprocal relationship from IQV graph: Reciprocal relationship from MEDP graph: d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, …
TMO Thermo Fisher Scientific Inc. 72% d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, the management of sales force effectiveness and the creation of a process whereby…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from MEDP graph: d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, …

Medpace Holdings, Inc. Customers

TickerNameConfidenceEvidence
CINRX-PHARMA CINRX-PHARMA 92% The Company recognized total revenue from CinRx of $ 6.1 million and $ 11.7 million during the three months ended March 31, 2026 and 2025, respectively, in the Company’s condensed consolidated statem…
LIB-THERAPEUTICS-LLC LIB-THERAPEUTICS-LLC 92% The Company recognized total revenue from LIB of $ 1.2 million and $ 2.2 million during the three months ended March 31, 2026 and 2025, respectively, in the Company’s condensed consolidated statement…
CLINTRAK CLINTRAK 90% We already provide access to such an information system, ClinTrak, to certain of our customers in connection with the services we provide to them.
IQV IQVIA Holdings Inc. 72% Reciprocal relationship from IQV graph: Reciprocal relationship from MEDP graph: Reciprocal relationship from IQV graph: Reciprocal relationship from MEDP graph: Reciprocal relationship from IQV grap…
IQV IQVIA Holdings Inc. 72% d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, the management of sales force effectiveness and the creation of a process whereby…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from MEDP graph: Reciprocal relationship from TMO graph: Reciprocal relationship from MEDP graph: Reciprocal relationship from TMO grap…
TMO Thermo Fisher Scientific Inc. 72% d and disciplined approach facilitates strong account evaluation, which results in increased focus by the sales team, the management of sales force effectiveness and the creation of a process whereby…
SERVICE-AGREEMENTS-LIB-THERAPEUTICS-LLC SERVICE-AGREEMENTS-LIB-THERAPEUTICS-LLC 62% laneous income (expense), net $ 4,056 $ ( 655 ) $ 7,068 14. RELATED PARTY TRANSACTIONS Employee Loans The Company periodically extends short term loans or advances to employees, typically upon commen…

Medpace Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MEDP-DEBT Debt stack $146.1M 90% Market cache reports total debt of $146.1M.

Medpace Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Medpace Holdings, Inc..

Medpace Holdings, Inc. Ownership

HolderNameConfidenceEvidence
MEDP-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 731 tracked holders.

Medpace Holdings, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TMO Thermo Fisher Scientific Inc. 100.00 1 ['customer', 'supplier']
IQV IQVIA Holdings Inc. 100.00 1 ['customer', 'supplier']
FTRE Fortrea Holdings Inc. 50.00 2
SVRA Savara Inc. 50.00 2
SUPN Supernus Pharmaceuticals, Inc. 50.00 2
RGEN Repligen Corporation 50.00 2
TECH Bio-Techne Corporation 50.00 2
BHPLF BHP Group Limited 50.00 2
CLLS Cellectis S.A. 50.00 2
ICLR ICON Public Limited Company 50.00 2
WAT Waters Corporation 50.00 2
DNA Ginkgo Bioworks Holdings, Inc. 50.00 2
GH Guardant Health, Inc. 50.00 2
IDXG Interpace Biosciences, Inc. 50.00 2
IMTX Immatics N.V. 50.00 2
TEM Tempus AI, Inc. 50.00 2
HRMY Harmony Biosciences Holdings, Inc. 50.00 2
HUMA Humacyte, Inc. 50.00 2
AZTA Azenta, Inc. 50.00 2
TWST Twist Bioscience Corporation 50.00 2